Cargando…
Structure and engineering of the minimal type VI CRISPR-Cas13bt3
Type VI CRISPR-Cas13 effector enzymes catalyze RNA-guided RNA cleavage and have been harnessed for various technologies, such as RNA detection, targeting, and editing. Recent studies identified Cas13bt3 (also known as Cas13X.1) as a miniature Cas13 enzyme, which can be used for knockdown and editing...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613696/ https://www.ncbi.nlm.nih.gov/pubmed/36027912 http://dx.doi.org/10.1016/j.molcel.2022.08.001 |
_version_ | 1783605512285192192 |
---|---|
author | Nakagawa, Ryoya Kannan, Soumya Altae-Tran, Han Takeda, Satoru N. Tomita, Atsuhiro Hirano, Hisato Kusakizako, Tsukasa Nishizawa, Tomohiro Yamashita, Keitaro Zhang, Feng Nishimasu, Hiroshi Nureki, Osamu |
author_facet | Nakagawa, Ryoya Kannan, Soumya Altae-Tran, Han Takeda, Satoru N. Tomita, Atsuhiro Hirano, Hisato Kusakizako, Tsukasa Nishizawa, Tomohiro Yamashita, Keitaro Zhang, Feng Nishimasu, Hiroshi Nureki, Osamu |
author_sort | Nakagawa, Ryoya |
collection | PubMed |
description | Type VI CRISPR-Cas13 effector enzymes catalyze RNA-guided RNA cleavage and have been harnessed for various technologies, such as RNA detection, targeting, and editing. Recent studies identified Cas13bt3 (also known as Cas13X.1) as a miniature Cas13 enzyme, which can be used for knockdown and editing of target transcripts in mammalian cells. However, the action mechanism of the compact Cas13bt3 remains unknown. Here, we report the structures of the Cas13bt3-guide RNA complex and the Cas13bt3-guide RNA-target RNA complex. The structures revealed how Cas13bt3 recognizes the guide RNA and its target RNA and provided insights into the activation mechanism of Cas13bt3, which is distinct from those of the other Cas13a/d enzymes. Furthermore, we rationally engineered enhanced Cas13bt3 variants and ultracompact RNA base editors. Overall, this study improves our mechanistic understanding of the CRISPR-Cas13 enzymes and paves the way for the development of efficient Cas13-mediated transcriptome modulation technologies. |
format | Online Article Text |
id | pubmed-7613696 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76136962022-10-11 Structure and engineering of the minimal type VI CRISPR-Cas13bt3 Nakagawa, Ryoya Kannan, Soumya Altae-Tran, Han Takeda, Satoru N. Tomita, Atsuhiro Hirano, Hisato Kusakizako, Tsukasa Nishizawa, Tomohiro Yamashita, Keitaro Zhang, Feng Nishimasu, Hiroshi Nureki, Osamu Mol Cell Article Type VI CRISPR-Cas13 effector enzymes catalyze RNA-guided RNA cleavage and have been harnessed for various technologies, such as RNA detection, targeting, and editing. Recent studies identified Cas13bt3 (also known as Cas13X.1) as a miniature Cas13 enzyme, which can be used for knockdown and editing of target transcripts in mammalian cells. However, the action mechanism of the compact Cas13bt3 remains unknown. Here, we report the structures of the Cas13bt3-guide RNA complex and the Cas13bt3-guide RNA-target RNA complex. The structures revealed how Cas13bt3 recognizes the guide RNA and its target RNA and provided insights into the activation mechanism of Cas13bt3, which is distinct from those of the other Cas13a/d enzymes. Furthermore, we rationally engineered enhanced Cas13bt3 variants and ultracompact RNA base editors. Overall, this study improves our mechanistic understanding of the CRISPR-Cas13 enzymes and paves the way for the development of efficient Cas13-mediated transcriptome modulation technologies. 2022-09-01 2022-08-25 /pmc/articles/PMC7613696/ /pubmed/36027912 http://dx.doi.org/10.1016/j.molcel.2022.08.001 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nakagawa, Ryoya Kannan, Soumya Altae-Tran, Han Takeda, Satoru N. Tomita, Atsuhiro Hirano, Hisato Kusakizako, Tsukasa Nishizawa, Tomohiro Yamashita, Keitaro Zhang, Feng Nishimasu, Hiroshi Nureki, Osamu Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title | Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title_full | Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title_fullStr | Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title_full_unstemmed | Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title_short | Structure and engineering of the minimal type VI CRISPR-Cas13bt3 |
title_sort | structure and engineering of the minimal type vi crispr-cas13bt3 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613696/ https://www.ncbi.nlm.nih.gov/pubmed/36027912 http://dx.doi.org/10.1016/j.molcel.2022.08.001 |
work_keys_str_mv | AT nakagawaryoya structureandengineeringoftheminimaltypevicrisprcas13bt3 AT kannansoumya structureandengineeringoftheminimaltypevicrisprcas13bt3 AT altaetranhan structureandengineeringoftheminimaltypevicrisprcas13bt3 AT takedasatorun structureandengineeringoftheminimaltypevicrisprcas13bt3 AT tomitaatsuhiro structureandengineeringoftheminimaltypevicrisprcas13bt3 AT hiranohisato structureandengineeringoftheminimaltypevicrisprcas13bt3 AT kusakizakotsukasa structureandengineeringoftheminimaltypevicrisprcas13bt3 AT nishizawatomohiro structureandengineeringoftheminimaltypevicrisprcas13bt3 AT yamashitakeitaro structureandengineeringoftheminimaltypevicrisprcas13bt3 AT zhangfeng structureandengineeringoftheminimaltypevicrisprcas13bt3 AT nishimasuhiroshi structureandengineeringoftheminimaltypevicrisprcas13bt3 AT nurekiosamu structureandengineeringoftheminimaltypevicrisprcas13bt3 |